Progyny Inc
NASDAQ:PGNY
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
18.01
28.42
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Progyny Inc
NASDAQ:PGNY
|
2.1B USD |
Loading...
|
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
266.6B USD |
Loading...
|
|
| US |
A
|
Anthem Inc
LSE:0HG8
|
80.1B USD |
Loading...
|
|
| US |
|
Elevance Health Inc
NYSE:ELV
|
76B USD |
Loading...
|
|
| US |
|
Humana Inc
NYSE:HUM
|
23.5B USD |
Loading...
|
|
| US |
|
Centene Corp
NYSE:CNC
|
20.4B USD |
Loading...
|
|
| US |
|
Molina Healthcare Inc
NYSE:MOH
|
9.4B USD |
Loading...
|
|
| US |
|
Healthequity Inc
NASDAQ:HQY
|
7.1B USD |
Loading...
|
|
| US |
M
|
Magellan Health Inc
F:MAH1
|
2.2B EUR |
Loading...
|
|
| BR |
|
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
6.9B BRL |
Loading...
|
|
| US |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
1.2B USD |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
Progyny Inc
Glance View
In a world where the concept of family is continually evolving, Progyny Inc. emerges as a pioneer, reshaping the landscape of fertility and family-building benefits. Founded with a mission to offer comprehensive fertility solutions, the company leverages a unique combination of personalized concierge service and cutting-edge technology to meet the growing demand for reproductive health services. Progyny's role in the industry is substantial, providing a suite of tailored benefits that include fertility treatments, egg freezing, genetic testing, and support services. Through its proprietary Smart Cycle plan, Progyny stands apart by integrating these services into a single, streamlined benefits package, reducing complexities and elevating the experience for patients and employers alike. The heart of Progyny's business model lies in its collaboration with employers, offering them the opportunity to include comprehensive fertility benefits as part of their health packages. By doing so, Progyny opens the door for companies to attract and retain talent in a competitive workforce, ensuring employees have access to vital reproductive assistance. The company generates revenue by partnering with these employers, who pay for the fertility benefits as part of their employee health plans. This innovative approach not only ensures recurring income for Progyny but also aligns the company’s success with positive health outcomes for its clients. As more organizations recognize the value in supporting employees' family-building journeys, Progyny’s influence and relevance in the market continue to grow, reinforcing its standing as a leader in fertility solutions.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Progyny Inc is 4.5%, which is below its 3-year median of 4.9%.
Over the last 3 years, Progyny Inc’s Net Margin has decreased from 6% to 4.5%. During this period, it reached a low of 3.9% on Dec 31, 2022 and a high of 6% on Sep 30, 2022.